| Fante et al. 1616. Fante JF, Machado HC, Juliato CRT, Benetti-Pinto CL, Brito LGO. Pelvic floor disorders in women with premature ovarian insufficiency: a cross-sectional study. Menopause. 2020;27(4):450-8. , 2020 |
Selection: ****
Comparability: *
Outcome: ** |
PFD (IU, POP, FI) and PFM assessment (PERFECT scale) |
Self-reported UI, POP, and FI symptoms
PFDI-20
KHQ |
The prevalence of self-reported UI was 27.33% and 37.33% for, respectively, POI and control women, with no statistically significant differences. Similarly, no differences were perceived between the groups with regard to POP and FI prevalence. The PERFECT scale presented similar scores on power, endurance, repetitions, and fast contractions between POI and control groups. |
| Tan et al. 88. Tan R, Pu D, Cao J, Ge H, Chang X, Ye G, et al. Prevalence of stress urinary incontinence in women with premature ovarian insufficiency. J Womens Health (Larchmt). 2018;27(12):1508-12. , 2018 |
Selection: **
Comparability: *
Outcome: ** |
SUI |
Self-administered questionnaire |
The prevalence of SUI in the POI group tended to be higher than that in the control group (20.9%, 30/149 vs. 16.2%, 49/303), although not significantly (p = 0.297). About 41.6% (62/149) of patients with POI received HT. Patients with POI and SUI were older (p = 0.018) and had higher BMI (p = 0.007) than women with POI without SUI (p = 0.007). |
| Melo et al. 99. Melo MHV, Micussi MTABC, Medeiros RD, Cobucci RN, Maranhão TMO, Gonçalves AK. Pelvic floor muscle thickness in women with polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2018;25(6):813-6. , 2018 |
Selection: ***
Comparability: *
Outcome: ** |
Pelvic Floor thickness |
Transperineal 3D ultrasound |
There was no difference between the thickness of the pelvic floor muscles (PCOS group: right 1.12 ± 0.5, left 1.0 ± 0.6 and control group: right 0.89 ± 0.6 and left 0.94 ± 0.4). However, the PCOS group exhibited a tendency to a greater thickness. This may be due to the state of hyperandrogenism or abdominal overload. |
| Taghavi et al. 1010. Taghavi SA, Bazarganipour F, Allan H, Khashavi Z, Reisi N, Dosha N, et al. Pelvic floor dysfunction and polycystic ovary syndrome. Hum Fertil (Camb). 2017;20(4):262-7. , 2017 |
Selection: ****
Comparability: *
Outcome: ** |
PFD (UI, POP, FI)) |
PFDI-20 |
Briefly, the reported pelvic organ prolapse (POP) symptoms were higher in the PCOS group (p=0.05). The mean PFD score in the HA+M+PCO group was higher compared to other phenotypes, although the difference did not reach a significant level (p>0.05). However, there was a significant positive correlation between the luteinizing hormone (LH) level and the POP symptom portion of the PFDI-20 (p<0.05). |
| Micussi et al. 1212. Micussi MT, Freitas RP, Varella L, Soares EM, Lemos TM, Maranhão TM. Relationship between pelvic floor muscle and hormone levels in polycystic ovary syndrome. Neurourol Urodyn. 2016;35(7):780-5. , 2016 |
Selection: ***
Comparability: *
Outcome: ** |
Electrical activity of PFM |
sEMG |
There was a difference in muscle tone (PCOS=59.9 mV and Control group=25.5 mV; p<0.0001) and MVC (PCOS=159.7 mV and Control group=63.7mV; p<0.0002) between the groups. The concentration of estradiol and testosterone showed a strong correlation with tone (r=0.9, r=0.8, respectively) and MVC (r=0.9, r=0.9 respectively) in women with PCOS. |
| Vassimon et al. 1313. Vassimon FI, Ferreira CH, Martins WP, Ferriani RA, Batista RL, Bo K. Surface electromyography and ultrasound evaluation of pelvic floor muscles in hyperandrogenic women. Int Urogynecol J. 2016;27(4):587-91. , 2016 |
Selection: **
Comparability: *
Outcome: ** |
PFM (electrical activity and pelvic floor thickness) |
sEMG/US |
There were no significant differences in PFM sEMG activity between PCOS and controls in any of the contractions: quick contraction (73.23 mV/ 71.56 mV; p=0.62), 8 s (55.77 mV/ 54.17 mV; p=0.74), and 60 s (49.26 mV/47.32 mV; p=0.68), respectively. There was no difference in PFM thickness during contractions evaluated by US between PCOS and controls (12.78 mm/ 13.43 mm; p=0.48). |
| Antônio et al. 1414. Antonio FI, Bo K, Ferriani RA, Sá MF, Sá Rosa e Silva AC, Ferreira CH. Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome. Int Urogynecol J. 2013;24(10):1709-14. , 2013 |
Selection: ***
Comparability: *
Outcome: ** |
PFM strength and UI |
Manometer Peritron; ICIQ-UI-SF |
There was no statistically significant difference in mean PFM strength between the PCOS and the control group: 2.7 cm H2O (95 % CI −6.2–11.6) p=0.55. The prevalence of UI was 18.6 % in the control group compared with 0 % in the PCOS group p<0.01. |
| Montezuma et al. 1515. Montezuma T, Antonio FI, Rosa e Silva AC, Sá MF, Ferriani RA, Ferreira CH. Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome. Clinics (Sao Paulo). 2011;66(11):1911-5. , 2011 |
Selection: ***
Comparability: *
Outcome: * |
UI symptoms |
ICIQ-SF, SF-36 |
The answers to the ICIQ-SF revealed a significant difference in urinary function between the groups, with 24% of the subjects in the control group with BMI > reporting urinary incontinence. The mean scores for the SF-36 questionnaire revealed that group II had the lowest quality of life. |
| Sahinkanat et al. 1111. Sahinkanat T, Ozturk E, Ozkan Y, Coskun A, Ekerbicer H. The relationship between serum testosterone levels and bladder storage symptoms in a female population with polycystic ovary syndrome. Arch Gynecol Obstet. 2011;284(4):879-84. , 2011 |
Selection: ***
Comparability: *
Outcome: ** |
Bladder storage symptoms |
PUFq |
A significant positive correlation was found between serum testosterone level and total, symptom and bother scores of the PUFq, symptoms of dyspareunia, urgency, nocturia, and bladder/pelvic pain. There was no correlation between the serum testosterone level and ultrasonographic findings such as bladder capacity, postvoid residual volume, and symptom of frequency. |
Thumbnail
